Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States
Nikita Sandeep Wagle(American Cancer Society), Hye‐Chung Kum(Texas A&M Health Science Center), David Washburn(Texas A&M Health Science Center), Amit G. Singal(Southwestern Medical Center), Nicole E. Rich(Parkland Health & Hospital System), Robert L. Ohsfeldt(Texas A&M University), Sulki Park(Texas A&M Health Science Center)
Cited by 38
Related Papers
Cancer statistics, 2023
|CA A Cancer Journal for Clinicians|2023|16.6k
Colorectal cancer statistics, 2023
|CA A Cancer Journal for Clinicians|2023|3.8k
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227
Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
|The American Journal of Medicine|2014|177